Published in Diabetes Metab Res Rev on October 01, 2011
Neurotrophic Factors in Cerebrospinal Fluid in Diabetic Patients With Polyneuropathy | NCT01718015
The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy. J Diabetes Complications (2012) 1.79
Assessing decreased sensation and increased sensory phenomena in diabetic polyneuropathies. Diabetes (2013) 1.00
Identification and prediction of diabetic sensorimotor polyneuropathy using individual and simple combinations of nerve conduction study parameters. PLoS One (2013) 0.96
Classification of the severity of diabetic neuropathy: a new approach taking uncertainties into account using fuzzy logic. Clinics (Sao Paulo) (2012) 0.96
Early electrophysiological abnormalities and clinical neuropathy: a prospective study in patients with type 1 diabetes. Diabetes Care (2013) 0.96
Diabetic neuropathy: one disease or two? Curr Opin Neurol (2012) 0.95
Diabetic neuropathy: mechanisms, emerging treatments, and subtypes. Curr Neurol Neurosci Rep (2014) 0.93
Conduction slowing in diabetic sensorimotor polyneuropathy. Diabetes Care (2013) 0.92
Differential reduction in corneal nerve fiber length in patients with type 1 or type 2 diabetes mellitus. J Diabetes Complications (2014) 0.85
Glucose control and diabetic neuropathy: lessons from recent large clinical trials. Curr Diab Rep (2014) 0.85
Quantification of transthyretin kinetic stability in human plasma using subunit exchange. Biochemistry (2014) 0.85
The characteristics of chronic inflammatory demyelinating polyneuropathy in patients with and without diabetes--an observational study. PLoS One (2014) 0.84
Preventing and treating foot complications associated with diabetes mellitus. Nat Rev Endocrinol (2015) 0.83
Safety of aerobic exercise in people with diabetic peripheral neuropathy: single-group clinical trial. Phys Ther (2014) 0.82
Identification of factors associated with sural nerve regeneration and degeneration in diabetic neuropathy. Diabetes Care (2013) 0.82
Ocular surface disease in patients with diabetic peripheral neuropathy. Br J Ophthalmol (2015) 0.81
Skeletal muscle morphology and contractile function in relation to muscle denervation in diabetic neuropathy. J Appl Physiol (1985) (2013) 0.81
Pathways in the diagnosis and management of diabetic polyneuropathy. Curr Diab Rep (2015) 0.81
Small- and large-fiber neuropathy after 40 years of type 1 diabetes: associations with glycemic control and advanced protein glycation: the Oslo Study. Diabetes Care (2013) 0.81
Effect of diabetic neuropathy severity classified by a fuzzy model in muscle dynamics during gait. J Neuroeng Rehabil (2014) 0.81
Decreased muscle endurance associated with diabetic neuropathy may be attributed partially to neuromuscular transmission failure. J Appl Physiol (1985) (2015) 0.80
Genetic Studies on Diabetic Microvascular Complications: Focusing on Genome-Wide Association Studies. Endocrinol Metab (Seoul) (2015) 0.80
Diabetic neuropathies. Continuum (Minneap Minn) (2014) 0.80
Recent Advances in Diagnostic Strategies for Diabetic Peripheral Neuropathy. Endocrinol Metab (Seoul) (2016) 0.79
The Facilitative Effect of Transcranial Direct Current Stimulation on Visuospatial Working Memory in Patients with Diabetic Polyneuropathy: A Pre-post Sham-Controlled Study. Front Hum Neurosci (2016) 0.76
High energy diets-induced metabolic and prediabetic painful polyneuropathy in rats. PLoS One (2013) 0.76
Serum Phosphorylated Neurofilament-Heavy Chain, a Potential Biomarker, is Associated With Peripheral Neuropathy in Patients With Type 2 Diabetes. Medicine (Baltimore) (2015) 0.75
Does prediabetes cause small fiber sensory polyneuropathy? Does it matter? J Neurol Sci (2015) 0.75
Is the C677T polymorphism in methylenetetrahydrofolate reductase gene or plasma homocysteine a risk factor for diabetic peripheral neuropathy in Chinese individuals? Neural Regen Res (2012) 0.75
Effects of exenatide on measures of diabetic neuropathy in subjects with type 2 diabetes: results from an 18-month proof-of-concept open-label randomized study. J Diabetes Complications (2015) 0.75
Morphological changes of the peripheral nerves evaluated by high-resolution ultrasonography are associated with the severity of diabetic neuropathy, but not corneal nerve fiber pathology in patients with type 2 diabetes. J Diabetes Investig (2014) 0.75
Entrapment neuropathies in diabetes mellitus. World J Diabetes (2016) 0.75
Angiogenin gene polymorphism: A risk factor for diabetic peripheral neuropathy in the northern Chinese Han population. Neural Regen Res (2013) 0.75
Metabolic Syndrome, Neurotoxic 1-Deoxysphingolipids and Nervous Tissue Inflammation in Chronic Idiopathic Axonal Polyneuropathy (CIAP). PLoS One (2017) 0.75
Elasticity of the tibial nerve assessed by sonoelastography was reduced before the development of neuropathy and further deterioration associated with the severity of neuropathy in patients with type 2 diabetes. J Diabetes Investig (2015) 0.75
Pharmacological treatment of diabetic peripheral neuropathy. P T (2015) 0.75
Physiology in Medicine: neuromuscular consequences of diabetic neuropathy. J Appl Physiol (1985) (2016) 0.75
NON-INVASIVE EVALUATION OF NERVE CONDUCTION IN SMALL DIAMETER FIBERS IN THE RAT. Physiol J (2013) 0.75
Diffusion tensor imaging of the sural nerve in normal controls. Clin Imaging (2014) 0.75
Association Between Metabolic Syndrome Components and Polyneuropathy in an Obese Population. JAMA Neurol (2016) 0.75
An 'Importance' Map of Signs and Symptoms to Classify Diabetic Polyneuropathy: An Exploratory Data Analysis. PLoS One (2015) 0.75
Comparison of diabetes patients with "demyelinating" diabetic sensorimotor polyneuropathy to those diagnosed with CIDP. Brain Behav (2013) 0.75
Temporal course of streptozotocin-induced diabetic polyneuropathy in rats. Neurol Sci (2014) 0.75
Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care (2005) 7.81
Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial. Ann Intern Med (2007) 6.00
Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial. Lancet Neurol (2008) 3.59
Lifestyle intervention for pre-diabetic neuropathy. Diabetes Care (2006) 3.47
Perspective: Transforming science into medicine: how clinician-scientists can build bridges across research's "valley of death". Acad Med (2012) 3.43
Diabetic somatic neuropathies. Diabetes Care (2004) 3.39
Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care (2010) 3.20
Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss. Nat Genet (2011) 3.16
Trends in the mortality burden associated with diabetes mellitus: a population-based study in Rochester, Minn, 1970-1994. Arch Intern Med (2003) 3.13
Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev (2004) 2.83
Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care (2006) 2.64
IV immunoglobulin in patients with myasthenia gravis: a randomized controlled trial. Neurology (2007) 2.61
Diabetic neuropathy: mechanisms to management. Pharmacol Ther (2008) 2.57
Kindlin-2 is an essential component of intercalated discs and is required for vertebrate cardiac structure and function. Circ Res (2008) 2.48
Does the prevailing hypothesis that small-fiber dysfunction precedes large-fiber dysfunction apply to type 1 diabetic patients? Diabetes Care (2014) 2.29
Challenges in design of multicenter trials: end points assessed longitudinally for change and monotonicity. Diabetes Care (2007) 2.29
Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy. PLoS Genet (2009) 2.23
High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J (2002) 2.18
Autonomic symptoms and diabetic neuropathy: a population-based study. Diabetes Care (2004) 1.99
Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes (2009) 1.99
Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol (2012) 1.99
Motor unit potential induced repetitive discharges (MIRDs): description of an unusual iterative discharge. Muscle Nerve (2013) 1.97
Stem cell technology for neurodegenerative diseases. Ann Neurol (2011) 1.93
Modeling chronic glycemic exposure variables as correlates and predictors of microvascular complications of diabetes. Diabetes Care (2006) 1.93
Microvascular complications of impaired glucose tolerance. Diabetes (2003) 1.88
Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patients. Stem Cells (2012) 1.87
Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nat Rev Neurol (2011) 1.85
Aligned electrospun nanofibers specify the direction of dorsal root ganglia neurite growth. J Biomed Mater Res A (2007) 1.83
Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial. Muscle Nerve (2010) 1.82
Auditory stream segregation in monkey auditory cortex: effects of frequency separation, presentation rate, and tone duration. J Acoust Soc Am (2004) 1.82
Mouse models of diabetic neuropathy. Neurobiol Dis (2007) 1.76
Short-term hyperglycemia produces oxidative damage and apoptosis in neurons. FASEB J (2005) 1.75
Carpal tunnel syndrome in patients with diabetic polyneuropathy. Diabetes Care (2002) 1.72
Physiological characterization of neuropathy in Fabry's disease. Muscle Nerve (2002) 1.70
Efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care (2011) 1.70
Oxidative stress and programmed cell death in diabetic neuropathy. Ann N Y Acad Sci (2002) 1.67
Autonomic dysfunction in obstructive sleep apnea is associated with impaired glucose regulation. Sleep Med (2007) 1.67
Neuropathy target esterase gene mutations cause motor neuron disease. Am J Hum Genet (2008) 1.66
Dyslipidemia-induced neuropathy in mice: the role of oxLDL/LOX-1. Diabetes (2009) 1.64
Energy expenditure, sex, and endogenous fuel availability in humans. J Clin Invest (2003) 1.62
Spectrotemporal analysis of evoked and induced electroencephalographic responses in primary auditory cortex (A1) of the awake monkey. Cereb Cortex (2007) 1.61
How does diabetes accelerate Alzheimer disease pathology? Nat Rev Neurol (2010) 1.60
Prostate cancer may trigger paraneoplastic limbic encephalitis: a case report and a review of the literature. Int J Urol (2012) 1.59
Control of cell survival by IGF signaling pathways. Growth Horm IGF Res (2002) 1.56
Reliability of the questionnaire for verifying stroke-free status. Cerebrovasc Dis (2003) 1.55
Drug safety is a barrier to the discovery and development of new androgen receptor antagonists. Prostate (2010) 1.54
Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy. Clin Ther (2005) 1.53
Hyperlipidemia: a new therapeutic target for diabetic neuropathy. J Peripher Nerv Syst (2009) 1.52
Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev (2012) 1.51
Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management. Diabetes Metab Res Rev (2011) 1.50
No evidence of microbleeds in ALS patients at 7 Tesla MRI. Amyotroph Lateral Scler (2010) 1.46
Monotonicity of nerve tests in diabetes: subclinical nerve dysfunction precedes diagnosis of polyneuropathy. Diabetes Care (2005) 1.46
SciMiner: web-based literature mining tool for target identification and functional enrichment analysis. Bioinformatics (2009) 1.45
SUMOylation of the mitochondrial fission protein Drp1 occurs at multiple nonconsensus sites within the B domain and is linked to its activity cycle. FASEB J (2009) 1.45
Neuropathy associated with microtubule inhibitors: diagnosis, incidence, and management. Clin Adv Hematol Oncol (2008) 1.45
Detection of diabetic sensorimotor polyneuropathy by corneal confocal microscopy in type 1 diabetes: a concurrent validity study. Diabetes Care (2012) 1.44
Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy. Am J Physiol Renal Physiol (2008) 1.44
Intracranial vessel wall imaging at 7.0-T MRI. Stroke (2011) 1.44
Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. Endocrinology (2006) 1.44
The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial. Diabetes Care (2003) 1.42
Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care (2014) 1.42
Fatigue during breast radiotherapy and its relationship to biological factors. Int J Radiat Oncol Biol Phys (2004) 1.41
Individual attributes versus composite scores of nerve conduction abnormality: sensitivity, reproducibility, and concordance with impairment. Muscle Nerve (2003) 1.41
Effect of multiple chronic conditions among working-age adults. Am J Manag Care (2011) 1.41
Glucose counterregulatory hormones in the 72-hour fast. Endocr Pract (2003) 1.40
Predictors of response to immunomodulation in patients with myasthenia gravis. Muscle Nerve (2012) 1.40
Mechanisms of disease: the oxidative stress theory of diabetic neuropathy. Rev Endocr Metab Disord (2008) 1.40
Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes. Endocrinology (2009) 1.39
IGF-I prevents glutamate-induced motor neuron programmed cell death. Neurobiol Dis (2004) 1.39
SOD2 protects neurons from injury in cell culture and animal models of diabetic neuropathy. Exp Neurol (2007) 1.38
Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch Neurol (2006) 1.38
The Utah Early Neuropathy Scale: a sensitive clinical scale for early sensory predominant neuropathy. J Peripher Nerv Syst (2008) 1.36
The design of electrospun PLLA nanofiber scaffolds compatible with serum-free growth of primary motor and sensory neurons. Acta Biomater (2008) 1.36
Phosphatidylinositol 3-kinase and Akt effectors mediate insulin-like growth factor-I neuroprotection in dorsal root ganglia neurons. FASEB J (2004) 1.33
Intracortical responses in human and monkey primary auditory cortex support a temporal processing mechanism for encoding of the voice onset time phonetic parameter. Cereb Cortex (2004) 1.33
Mitochondria in DRG neurons undergo hyperglycemic mediated injury through Bim, Bax and the fission protein Drp1. Neurobiol Dis (2006) 1.33
Translational stem cell therapy for amyotrophic lateral sclerosis. Nat Rev Neurol (2011) 1.32
Longitudinal 1H MRS changes in mild cognitive impairment and Alzheimer's disease. Neurobiol Aging (2006) 1.28
Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I safety trial, technical note, and lumbar safety outcomes. Neurosurgery (2012) 1.27
Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy. J Peripher Nerv Syst (2003) 1.26
Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice. Proc Natl Acad Sci U S A (2010) 1.26
Maximal isokinetic and isometric muscle strength of major muscle groups related to age, body mass, height, and sex in 178 healthy subjects. Eur J Appl Physiol (2011) 1.26
Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05). Radiother Oncol (2004) 1.25